Oncology Drugs List of articles

ELIQUENT Japan > Oncology Drugs

2026.09.15

Medical,balancing,act.,a,group,of,medicine,pills,and,antibiotics

Japan Joins FDA’s Project Orbis to Accelerate Global Oncology Drug Approvals

Introduction to Project Orbis is an international regulatory collaboration program established by the FDA Onco […]

2025.03.11

Medical,balancing,act.,a,group,of,medicine,pills,and,antibiotics

2024 New Drug Approvals in Japan: Company Rankings and Trends

Overview of New Drug ApprovalsAccording to the report (2024年 国内新薬承認取得数ランキング…最多は11承認のアストラゼネカ、新規有効成分はファイザーがトップ | […]

COMPANY

Company Name: Eliquent Japan, Inc.
Location: Shinjuku i-Land Tower 41F, 6-5-1 Nishi Shinjuku, Shinjuku-ku 163-1341 Tokyo, Japan
Representative Director, CEO: Shunsuke Iwano
Business Scope: Regulatory Consulting
 Phone:+81-3-6304-5570